Markets:

Overview

News

Currencies

International

Treasuries

iShares Biotechnology ETF (NQ:IBB)

170.03 -3.80 (-2.19%)

Streaming Delayed Price Updated: 2:52 PM EST, Dec 1, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

27 28 Next >

Daily Biotech Pulse: Teva's Opioids Settlement, Criminal Investigation Against Cassava, Durable Responses For IN8bio's Leukemia Therapy ↗

July 27, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate ↗

July 26, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Expectations, Implications And Possible Impacts On The Market ↗

July 25, 2022

Investors believe that the Fed Funds rate is close to peaking and will begin to decline in 2023 and 2024.

Via Talk Markets

Daily Biotech Pulse: KKR Invests In Medicine Start-Up, Revelation Bio Aces Allergic Rhinitis Study, Tonix Pharma Ends COVID-19 Antiviral Pact ↗

July 25, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Market Predictions 2022: When Will Stocks Go Back Up? ↗

July 22, 2022

As investors look to jump back in, they’re asking, “when will stocks go back up?” It turns out that the bulls and bears are both right.

Via InvestorPlace

Daily Biotech Pulse: VistaGen's Anxiety Study Fails, Silverback To Merge With Firm Developing EpiPen Alternative, Setback For Liminal's Lead Asset ↗

July 22, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Daily Biotech Pulse: Liver Disease-Focused Gene Therapy Pact, Assembly Bio Stops HBV Infection Trial, X4 Pharma Looks For Partners ↗

July 21, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

The Daily Biotech Pulse: CDC AdComm Backs Novavax COVID-19 Vaccine, European Approval For PTC Therapeutics' Gene Therapy, Merck's Keytruda Flunks In Head, Neck Cancer Study ↗

July 20, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings ↗

July 19, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

7 Biotech Stocks to Buy for Q3 ↗

July 18, 2022

These biotech stocks could be good buys due for a few reasons, including great R&D pipelines and treatments with promising market potential.

Via InvestorPlace

The Daily Biotech Pulse: Sesen Bio Stops Lead Assest Development In US, FDA Approves Eton Pharma's Partial Seizures Drug, Bavarian Nordic Inks Multiple Supply Pact For Monkeypox Vaccine ↗

July 18, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

The Daily Biotech Pulse: FDA Signs Off Cancer Therapy Trials For NexImmune, Omega Therapeutics, Endo To Develop Rare Hereditary Skin Disease Candidate ↗

July 15, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures ↗

July 14, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

USD & EUR: Is This the Dollar’s Last Hurrah? ↗

July 13, 2022

The euro has been under pressure recently, with investors pulling their money out in favor of the haven currency—the US Dollar.

Via Talk Markets

The Daily Biotech Pulse: AstraZeneca's COVID-19 Vaccine As Effective As mRNA Shots, Humanigen's Lenzilumab Disappoints In COVID-19 Study, Positive Preclinical Data From Hoth's Alzheimer's Program ↗

July 13, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Strengthen Your Portfolio With Real Assets ↗

July 12, 2022

As we head into the second half of the year, it's essential to keep an eye on real assets. Real asset prices provide clues to what's happening in the global economy and can provide valuable insight.

Via Talk Markets

The Daily Biotech Pulse: GSK To Supply 50M Flu Vaccine Doses To US, FDA Lifts Hold On Greenwich's Cancer Immunotherapy Trial, Connect Biopharma Sees CBP-201 Topline Data Sooner ↗

July 12, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

What Are the Corporate Bond Markets Telling Us? ↗

July 11, 2022

Keep an eye on these two corporate bonds ETFs to stay ahead of the curve in the stock market.

Via Talk Markets

The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death ↗

July 11, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Walking The Fine Line - Five Indicators To Tell You When It Is Safe To Invest ↗

July 10, 2022

Daily, forecasters claim that we have probably started a recession (NOT) and that Energy prices will continue to climb (while they’ve declined over 10% in the past few weeks).

Via Talk Markets

5 Best Stocks to Buy if You Have $100 to Spend ↗

July 10, 2022

My son became an investor this year, taking a job that pays more than his single, frugal lifestyle consumes. He asked me what stocks he might buy with

Via InvestorPlace

The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug ↗

July 08, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

7 Best Biotech Stocks to Buy in July 2022 ↗

July 08, 2022

The best biotech stocks to buy are a lot like the best computer stocks 40 years ago; the biggest similarity is how hard they are to predict.

Via InvestorPlace

The 3 Best Retirement Stocks for Gen-Z Investors ↗

July 07, 2022

Older generations are showing their worry and providing a huge opportunity in the market's best retirement stocks for Gen-Z investors to buy

Via InvestorPlace

The Daily Biotech Pulse: Merck's Seagen Buyout Advances, Adverum Restructures, Pharmacists Get OK To Prescribe Pfizer COVID-19 Pill ↗

July 07, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Dislocation-Fundamentals Versus Price in Natural Gas ↗

July 06, 2022

Global demand for natural gas continues to skyrocket in the wake of Russia's invasion of Ukraine.

Via Talk Markets

The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate ↗

July 06, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Did ARKK Bottom? ↗

July 05, 2022

ARKK may be the most extraordinary example of sheer brilliance and horrific money management combined.

Via Talk Markets

3 Biotech Stocks to Sell Now ↗

July 05, 2022

These biotech stocks remain vulnerable to more downside. Their charts remain broken and resistance looms ominously overhead.

Via InvestorPlace

The Daily Biotech Pulse: AstraZeneca Goes Shopping, TYME Technologies & Syros Pharma Merger, FDA Clears Vertex Pharma's Stem Cell-Based Diabetes Therapy Study ↗

July 05, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

< Previous 1 2

...

7 8 9 10 11 12 13 14 15

...

27 28 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

iShares Biotechnology ETF (NQ:IBB)

All News about iShares Biotechnology ETF

Starting at $3.75/week.

Subscribe Today